General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Balance Sheets

v3.22.4
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Dec. 31, 2020
Current assets:      
Cash $ 14,063,642 $ 10,574,292 $ 663,457
Prepaid expenses and other current assets   98,203 83,048
Total current assets 14,779,865 10,672,495 746,505
Prepaid expenses and other current assets 460,917 54,537  
Australia research and development incentives receivable 255,306 43,666  
Deferred offering costs   651,582  
Other assets 2,800 3,122  
Total assets 14,782,665 11,327,199 746,505
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)      
Accounts payable 1,019,093 960,401 154,886
Accrued expenses   1,074,324 838,810
Due to related parties     7,037
Convertible notes payable - current portion     10,586
Loan payable to officer     21,367
Deferred compensation   111,271 661,058
Total current liabilities 2,456,293 2,145,996 1,693,744
Accrued expenses 1,437,200 1,185,595  
Commitments and contingencies
Convertible notes payable, net of current portion     332,841
Convertible notes payable, related parties     98,960
Derivative liability for embedded conversion features on convertible notes payable and convertible notes payable, related parties     127,000
Warrant liability 215,705   85,260
Simple agreement for future equity payable     25,000
Total liabilities 2,671,998 2,145,996 2,362,805
Commitments and contingencies
Preferred stock, $0.0001 par value, 70,000,000 shares authorized, 0 shares issued and outstanding
Common stock, $0.0001 par value, 30,000,000 shares authorized, 7,584,980 and 4,433,644 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively 1,095 758 443
Additional paid-in capital 52,222,752 37,618,438 12,599,585
Accumulated deficit (40,061,534) (28,437,993) (15,934,113)
Stock subscription receivable     2,002
Total MAIA Biotechnology, Inc. stockholders' equity (deficit)   9,181,203 (3,336,087)
Noncontrolling interests     1,719,787
Total stockholders' equity (deficit) 12,110,667 9,181,203 (1,616,300)
Accumulated other comprehensive income (loss) (51,646)    
Total liabilities and stockholders' equity (deficit) 14,782,665 11,327,199 746,505
Total liabilities and stockholders' equity (deficit) 14,782,665 11,327,199 746,505
Current liabilities:      
Warrant liability 215,705   85,260
Total liabilities $ 2,671,998 $ 2,145,996 $ 2,362,805